Diagnosis and management of the adnexal mass

American Family Physician

Volumn 57, Issue 10, 1998, Pages 2471-2476

  Drake, Janet ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; CHORIONIC GONADOTROPIN BETA SUBUNIT; LACTATE DEHYDROGENASE; ORAL CONTRACEPTIVE AGENT;

ADNEXA DISEASE; CORPUS LUTEUM; ECHOGRAPHY; ECTOPIC PREGNANCY; ENDOMETRIUM TUMOR; FEMALE; FOLLICLE CYST; HORMONAL THERAPY; HUMAN; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; OVARY POLYCYSTIC DISEASE; OVARY TUMOR; POSTMENOPAUSE; PREMENOPAUSE; REVIEW; TUBOOVARIAN ABSCESS; UTERUS MYOMA;

ADNEXAL DISEASES; ALGORITHMS; CA-125 ANTIGEN; DECISION TREES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; OVARIAN CYSTS; PATIENT EDUCATION; POSTMENOPAUSE; PREGNANCY; PREGNANCY COMPLICATIONS; PREMENOPAUSE; TEACHING MATERIALS;

EID: 0032524743     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Curtin JP. Management of the adnexal mass. Gynecol Oncol 1994;55(3 Pt 2):S42-6.
2. Russell DJ. The female pelvic mass. Diagnosis and management. Med Clin North Am 1995;79:1481-93.
3. Koonings PP, Campbell K, Mishell DR Jr, Grimes DA. Relative frequency of primary ovarian neoplasms: a 10-year review. Obstet Gynecol 1989;74:921-6.
4. Herrmann UJ. Sonographic patterns of ovarian tumors. Clin Obstet Gynecol 1993;36:375-83.
5. Weissman AM, Barloon TJ. Transvaginal ultrasonog- raphy in nonpregnant and postmenopausal women. Am Fam Physician 1996;53:2065-72.
6. Goldstein SR. Conservative management of small postmenopausal cystic masses. Clin Obstet Gynecol 1993;36:395-401.
7. Brooks SE. Preoperative evaluation of patients with suspected ovarian cancer. Gynecol Oncol 1994;55(3 Pt 2):S80-90.
8. Claus EB, Schwartz PE. Familial ovarian cancer: update and clinical applications. Cancer 1995;76 (10 suppl):1998-2003.
9. Gallup DG, Talledo OE. Management of the adnexal mass in the 1990s. South Med J 1997;90:972-81.
10. NIH develops consensus statement on ovarian cancer. Am Fam Physician 1994;50:213-6.
11. Mishell DR Jr. Noncontraceptive benefits of oral contraceptives. J Reprod Med 1993;38(12 Suppl):1021-9.
12. Grimes DA, Godwin AJ, Rubin A, Smith JA, Lacarra M. Ovulation and follicular development associated with three low-dose oral contraceptives: a randomized controlled trial. Obstet Gynecol 1994;83:29-34.
13. Egarter C, Putz M, Strohmer H, Speiser P, Wenzl R, Huber J. Ovarian function during low-dose oral contraceptive use. Contraception 1995;51(6):329-33.
14. DiSaia PJ, Creasman WT. The adnexal mass and early ovarian cancer. In: Clinical gynecologic oncology. 5th ed. St Louis: Mosby, 1997:261.
15. Schutter EM, Kenemans P, Sohn C, Kristen P, Crombach G, Westermann R, et al. Diagnostic value of pelvic examination, ultrasound, and serum CA 125 in postmenopausal women with a pelvic mass. An international multicenter study. Cancer 1994;74:1398-406.
16. Morrow CP, Curtin JP, Townsend DE. Tumors of the ovary: classification of the adnexal mass. In: Synopsis of gynecologic oncology. 4th ed. New York: Churchill Livingstone, 1993:224.